PT  - JOURNAL ARTICLE
AU  - Josephine N. A. Tetteh
AU  - Van Kinh Nguyen
AU  - Esteban A. Hernandez-Vargas
TI  - COVID-19 Network Model to Evaluate Vaccine Strategies towards Herd Immunity
AID  - 10.1101/2020.12.22.20248693
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.22.20248693
4099  - http://medrxiv.org/content/early/2020/12/22/2020.12.22.20248693.short
4100  - http://medrxiv.org/content/early/2020/12/22/2020.12.22.20248693.full
AB  - With more than 60 million confirmed cases and more than 1.5 million deaths, SARS-CoV-2 has paralyzed our societies, leading to self isolation and quarantine for several months. A COVID-19 vaccine remains a critical element in the eventual solution to this public health crisis. Two vaccines are ready to be mass produced and eventually supplied to the population. Here, we develop an epidemiological network model able to represent COVID-19 pandemic dynamics of different countries such as in Italy. Stochastic computational simulations identify the necessary number of vaccines and vaccine efficacy thresholds capable of preventing an epidemic whilst adhering to lockdown guidelines. Assuming a vaccine efficacy of 100% in a mass vaccination program, at least 60% of a given population should be vaccinated to obtain herd immunity. Otherwise, new waves of COVID-19 would be reported. However, reaching 60% of the population will be an unprecedented mass immunisation campaign that will take several months and millions of dollars. If the vaccine efficacy reports lower levels of efficacy in practice, then the coverage of vaccination would be needed to be even higher. Simulations suggest that the “Ring of Vaccination” strategy, vaccinating susceptible contact and contact of contacts, would be a more tractable vaccine strategy to prevent the new waves of COVID-19 meanwhile a high percent of the population is vaccinated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the Deutsche Forschungsgemeinschaft (HE7707/5-1), the Alfons und Gertrud Kassel-Stiftung and the Mexican National Science and Technology Council (CONACYT)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:-All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code and the data-sets supporting this article have been uploaded as electronic supplementary material. https://github.com/Josephine-Tetteh/COVID-19-Network-Model.git